Defender Capital, LLC.

SEC CIK: 0001766929
Latest filing: Oct 1, 2026

SEC filings (opens in a new tab)

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Defender Capital, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overview All 13F holders of ARWR Full Q3 2026 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of ARWR by Defender Capital, LLC., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−4,000−100.0%	Sold out	Holders
Q1 2021	4,000	$270.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.